Liver biopsy is an imperfect standard for the assessment of chronic hepatitis C liver fibrosis. In this study, the diagnostic role of proteome-derived protein markers and the usefulness of a protein-based index were assessed.Evaluation StudiesJournal ArticleSCOPUS: ar.jinfo:eu-repo/semantics/publishe
Background & Aims: Noninvasive tests cannot differentiate between adjacent stages of fibrosis, which...
Proteomics can help to discover and quantify novel biomarkers and we show how this is achieved using...
Two-dimensional gel electrophoresis (2-DE) is often used to separate plasma or serum proteins in an ...
Liver biopsy is the reference standard for assessing liver fibrosis and no reliable serum biomarkers...
Liver biopsy is the reference standard for assessing liver fibrosis and no reliable non-invasive dia...
Background: Liver biopsy is currently the gold standard for assessing liver fibrosis, and no reliabl...
Introduction: Liver biopsy is the reference standard for assessing liver fibrosis, and no reliable n...
The inventors have proposed a novel panel of human serum protein biomarkers for diagnosing hepatic f...
Liver biopsy is the reference standard for assessing liver fibrosis and no reliable non-invasive dia...
BACKGROUND: Liver biopsy is currently the gold standard for assessing liver fibrosis, and no reliabl...
The inventors have proposed a novel panel of human plasma protein biomarkers for diagnosing hepatic ...
Liver fibrosis/cirrhosis is a serious health issue in hepatitis C virus (HCV-) infected patients and...
Liver fibrosis is a serious health issue for many liver patients and is currently diagnosed using li...
The inventors have proposed a novel panel of human serum protein biomarkers for diagnosing hepatic f...
Chronic liver disease (CLD) is a major and growing healthcare burden but is asymptomatic until liver...
Background & Aims: Noninvasive tests cannot differentiate between adjacent stages of fibrosis, which...
Proteomics can help to discover and quantify novel biomarkers and we show how this is achieved using...
Two-dimensional gel electrophoresis (2-DE) is often used to separate plasma or serum proteins in an ...
Liver biopsy is the reference standard for assessing liver fibrosis and no reliable serum biomarkers...
Liver biopsy is the reference standard for assessing liver fibrosis and no reliable non-invasive dia...
Background: Liver biopsy is currently the gold standard for assessing liver fibrosis, and no reliabl...
Introduction: Liver biopsy is the reference standard for assessing liver fibrosis, and no reliable n...
The inventors have proposed a novel panel of human serum protein biomarkers for diagnosing hepatic f...
Liver biopsy is the reference standard for assessing liver fibrosis and no reliable non-invasive dia...
BACKGROUND: Liver biopsy is currently the gold standard for assessing liver fibrosis, and no reliabl...
The inventors have proposed a novel panel of human plasma protein biomarkers for diagnosing hepatic ...
Liver fibrosis/cirrhosis is a serious health issue in hepatitis C virus (HCV-) infected patients and...
Liver fibrosis is a serious health issue for many liver patients and is currently diagnosed using li...
The inventors have proposed a novel panel of human serum protein biomarkers for diagnosing hepatic f...
Chronic liver disease (CLD) is a major and growing healthcare burden but is asymptomatic until liver...
Background & Aims: Noninvasive tests cannot differentiate between adjacent stages of fibrosis, which...
Proteomics can help to discover and quantify novel biomarkers and we show how this is achieved using...
Two-dimensional gel electrophoresis (2-DE) is often used to separate plasma or serum proteins in an ...